faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.",The Lancet,2025,10.1016/S0140-6736(25)00355-1,https://experts.mcmaster.ca/display/publication3554906,2025-07-27T15:11:48.046053
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,"National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.",The Lancet,2024,10.1016/S0140-6736(24)01548-4,https://experts.mcmaster.ca/display/publication3488451,2025-07-27T15:11:48.046056
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.,The Lancet Public Health,2024,10.1016/S2468-2667(24)00166-X,https://experts.mcmaster.ca/display/publication3476553,2025-07-27T15:11:48.046057
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.",Lancet Neurology,2024,10.1016/S1474-4422(24)00369-7,https://experts.mcmaster.ca/display/publication3472515,2025-07-27T15:11:48.046058
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.",The Lancet Infectious Diseases,2024,10.1016/S1473-3099(24)00176-2,https://experts.mcmaster.ca/display/publication3476119,2025-07-27T15:11:48.046059
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021",The Lancet,2024,10.1016/s0140-6736(24)00933-4,https://experts.mcmaster.ca/display/publication3431489,2025-07-27T15:11:48.046060
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,"Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021",The Lancet,2024,10.1016/s0140-6736(24)00550-6,https://experts.mcmaster.ca/display/publication3411191,2025-07-27T15:11:48.046062
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021",The Lancet,2024,10.1016/s0140-6736(24)00757-8,https://experts.mcmaster.ca/display/publication3429919,2025-07-27T15:11:48.046062
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B,Cochrane Database of Systematic Reviews,2024,10.1002/14651858.cd014544.pub2,https://experts.mcmaster.ca/display/publication3403413,2025-07-27T15:11:48.046063
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Cytisine for smoking cessation: A systematic review and meta-analysis,Drug and Alcohol Dependence,2023,10.1016/j.drugalcdep.2023.110936,https://experts.mcmaster.ca/display/publication3288678,2025-07-27T15:11:48.046064
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.102228,https://experts.mcmaster.ca/display/publication3307056,2025-07-27T15:11:48.046065
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Mo1092 ENDOSCOPIC ACTIVITY AND ITS RELATIONSHIP TO PATIENT-RELEVANT OUTCOMES IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC LITERATURE REVIEW,Gastroenterology,2023,10.1016/s0016-5085(23)02734-8,https://experts.mcmaster.ca/display/publication3585373,2025-07-27T15:11:48.046066
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors,Value in Health,2022,10.1016/j.jval.2022.04.724,https://experts.mcmaster.ca/display/publication2716673,2025-07-27T15:11:48.046067
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature,Journal of Thrombosis and Haemostasis,2022,10.1111/jth.15723,https://experts.mcmaster.ca/display/publication2182254,2025-07-27T15:11:48.046068
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders,European Journal of Haematology,2022,10.1111/ejh.13731,https://experts.mcmaster.ca/display/publication2158375,2025-07-27T15:11:48.046069
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Non-clotting factor therapies for preventing bleeds in people with hemophilia,Cochrane Database of Systematic Reviews,2021,10.1002/14651858.cd014544,https://experts.mcmaster.ca/display/publication2129800,2025-07-27T15:11:48.046070
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B,Cochrane Database of Systematic Reviews,2021,10.1002/14651858.cd014201,https://experts.mcmaster.ca/display/publication2126820,2025-07-27T15:11:48.046071
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States,Journal of Infection and Public Health,2020,10.1016/j.jiph.2019.06.010,https://experts.mcmaster.ca/display/publication3400839,2025-07-27T15:11:48.046072
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,Relative Clinical and Cost Burden of Community-Acquired Pneumonia Hospitalizations in Older Adults in the United States—A Cross-Sectional Analysis,Vaccines,2018,10.3390/vaccines6030059,https://experts.mcmaster.ca/display/publication3400840,2025-07-27T15:11:48.046073
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,PHS79 Relative Clinical and Economic Burden of Community Acquired Pneumonia in the Elderly,Value in Health,2018,10.1016/j.jval.2018.04.879,https://experts.mcmaster.ca/display/publication3585375,2025-07-27T15:11:48.046074
Omotola Olasupo,olasupo@mcmaster.ca,journal_articles,PIN71 Missed Opportunities for Influenza and Pneumococcal Vaccinations in the Elderly in the US - A Cross-Sectional Analysis,Value in Health,2018,10.1016/j.jval.2018.04.1083,https://experts.mcmaster.ca/display/publication3585374,2025-07-27T15:11:48.046075
Omotola Olasupo,olasupo@mcmaster.ca,conferences,ENDOSCOPIC ACTIVITY AND ITS RELATIONSHIP TO PATIENT-RELEVANT OUTCOMES IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC LITERATURE REVIEW,Gastroenterology,2023,,https://experts.mcmaster.ca/display/publication3604602,2025-07-27T15:11:48.046076
Omotola Olasupo,olasupo@mcmaster.ca,conferences,COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS,Value in Health,2022,,https://experts.mcmaster.ca/display/publication2424575,2025-07-27T15:11:48.046077
Omotola Olasupo,olasupo@mcmaster.ca,conferences,Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study,Blood,2021,10.1182/blood-2021-147550,https://experts.mcmaster.ca/display/publication2428077,2025-07-27T15:11:48.046078
Omotola Olasupo,olasupo@mcmaster.ca,conferences,Missed Opportunities for Influenza and Pneumococcal Vaccinations in Adults in the United States,Pharmacoepidemiology and Drug Safety,2017,,https://experts.mcmaster.ca/display/publication3604605,2025-07-27T15:11:48.046079
